Skip to content
Click For Our Latest Print Edition
  • Home
  • Events | Things To Do
  • Dining
  • Music
  • Culture
  • Best of SF
  • Cannabis
  • Top Stories
  • Sponsored
  • Film
  • Quicklinks
    • News
    • Free Stuff
    • Newsletters
    • Archives
  • About SF Weekly
    • About Us
    • Advertise
    • Contact Us
image/svg+xml
  • Events | Things To Do
  • Dining
  • Music
  • Culture
  • Film
  • Podcasts
  • Best of SF
  • Cannabis
Chem Tales
Do We Really Need 4/20 at This Point?
by Zack Ruskin • 04/24/2019 1:11 pm

The monetization of an annual celebration of cannabis culture.

Read Story

Your Bay Area Guide to 4/20
by Zack Ruskin • 04/18/2019 8:46 am

The second year of festivities since recreational cannabis went legit has something for stoners of every stripe.

Read Story

Low Grades for High Times 100 of 2019
by Zack Ruskin • 04/10/2019 5:18 pm

The legendary cannabis publication misses the mark — while patting itself on the back.

Read Story

Chem Tales: Cannabis Shark Tank
by Zack Ruskin • 04/03/2019 3:12 pm

Six hopefuls pitched their pot concepts to a panel of judges in hopes of netting a $10,000 prize.

Read Story

Chem Tales: Lost Cat Raises Funds for Firefighters
by Zack Ruskin • 03/28/2019 6:05 am

Harry’s Harvest honors a fallen feline while offering aid to those on the frontline.

Read Story

LeafWorks Uncovers the Dirt on Cannabis DNA
by Zack Ruskin • 03/21/2019 7:00 am

The Sebastopol company lays the groundwork for quality assurance in the pot industry.

Read Story

ECO Cannabis Proves Equity Programs Can Work
by Zack Ruskin • 03/06/2019 2:28 pm

The Telegraph Avenue dispensary earned its license by supporting a number of equity applicants — and hiring people who’ve been incarcerated for cannabis-related crimes.

Read Story

Chem Tales: Legal Cannabis Sales for 4/20?
by Zack Ruskin • 02/27/2019 12:30 am

A new permitting program aims to regulate pot purchases — but not consumption — at certain large-scale cultural festivities. Again: not consumption.

Read Story

S.F. Approves Its First Equity Program Dispensary
by Zack Ruskin • 02/20/2019 12:54 pm

Cole Ashbury Group CEO Shawn Richard hopes his efforts will serve as a blueprint for future applicants.

Read Story

Chem Tales: Apothecarium Acquired!
by Zack Ruskin • 02/11/2019 3:53 pm

Toronto’s TerrAscend spends $118 million to buy one of San Francisco’s most popular dispensaries.

Read Story

  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • Last
Please Consider Disabling Your Ad Blocker

Trending

  • 7 Best Asian Sites to Meet Asian Women – Cost & Tips in 2022
  • Non Fungible Films: Discover Why People are Buying NFTs
  • Serene Tree: Best New Delta-10 THC Products
  • Follicle Revival Hair Growth Supplement Review – Ingredients That Work?
  • Managing your Finances as an Esports Player
  • Draeger’s to reopen culinary school July 6 with expanded repertoire
  • Kelly Clarkson CBD Gummies (Scam EXPOSED) Natures Only CBD Gummies Where To Buy?
Please Consider Disabling Your Ad Blocker
  • Top Stories
  • News
  • Dining
  • Music
  • Culture
  • Sponsored
  • Film
Quicklinks
  • Events
  • Free Stuff
  • Newsletters
  • Archives
About SF Weekly
  • About Us
  • Advertise
  • Contact Us
image/svg+xml
© 2022, SF Weekly and SFEMC
  • Terms of Use
  • Privacy Policy
 Tweet
 Copy
 E-mail
 Tweet
 Copy
 E-mail
 Tweet
 Copy
 E-mail